---
title: "ARTV: AlloNK achieved 71% ACR50 in refractory RA and is advancing to a pivotal phase III trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291343969.md"
description: "AlloNK, a scalable allogeneic NK cell therapy, demonstrated high efficacy and safety in refractory RA, with 71% ACR50 rates and durable responses. A phase III trial will launch soon, targeting a large unmet market, with additional data and indications expected over the next two years.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-30T23:31:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291343969.md)
  - [en](https://longbridge.com/en/news/291343969.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291343969.md)
generator: "portal-rs"
---

# ARTV: AlloNK achieved 71% ACR50 in refractory RA and is advancing to a pivotal phase III trial

AlloNK, a scalable allogeneic NK cell therapy, demonstrated high efficacy and safety in refractory RA, with 71% ACR50 rates and durable responses. A phase III trial will launch soon, targeting a large unmet market, with additional data and indications expected over the next two years.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ARTV.US](https://longbridge.com/en/quote/ARTV.US.md)

## Related News & Research

- [SYNACT: Positive Phase 2b results for resomelagon in RA drive Phase 3 plans and strategic financing](https://longbridge.com/en/news/296439044.md)
- [Xtant Medical partners with BioHorizons for exclusive dental distribution of allogeneic growth factor tech in US, Canada](https://longbridge.com/en/news/297181832.md)
- [NIQ report finds nearly 75% of shoppers use AI for product discovery](https://longbridge.com/en/news/297162187.md)
- [HCW Biologics says TGF-β trap-IL-15 fusion expands CD8+ T, NK cells in human studies](https://longbridge.com/en/news/296919099.md)
- [74% of Shoppers Use AI for Discovery—NIQ Showcases What That Means for the Consumer Purchase Journey in New Report | NIQ Stock News](https://longbridge.com/en/news/297164186.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**